Steven Dood, MD
Family Medicine · Perrysburg, OHNPI 1730140203
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Novo Nordisk at 24.3% of the total. Reporting peaked in 2021 at $393 and has fallen 95.5% since, to $18 in 2025.
Across 38 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$141
- AbbVie$99
- Alnylam Pharmaceuticals Inc.$56
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$54
- Boehringer Ingelheim$35
- USWM, LLC$29
- plus $166 from 10 others
What the payments were for
- Food & beverage$580100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $141 |
| AbbVie(2 entities) | 6 | $99 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Boehringer Ingelheim | 2 | $35 |
| USWM, LLC | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $28 |
| Lilly USA, LLC | 2 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Abbott | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Almatica Pharma LLC | 1 | $11 |
How this compares
$580 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $5,393 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $2,986 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $691 |
| Omeprazole | 54 | $437 |
| Levothyroxine Sodium | 62 | $367 |
| Pregabalin | 11 | $365 |
| Simvastatin | 19 | $323 |
| Amitriptyline Hcl | 30 | $286 |
| Glimepiride | 19 | $238 |
| Gabapentin | 30 | $226 |
| Losartan Potassium | 33 | $221 |
| Hydroxyzine Hcl | 19 | $220 |
| Hydrochlorothiazide | 56 | $215 |
| Alprazolam | 14 | $208 |
| Metformin Hcl | 53 | $196 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Perrysburg
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.